An extension study of the patients enrolled in Acute Graft Versus Host Disease (GVHD) prophylaxis study (protocol no. FJ-506E-BT01) to assess safety and efficacy of GVHD prophylaxis of a tacrolimus new oral formulation (MR4).
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2006
At a glance
- Drugs Tacrolimus (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 27 Sep 2006 Status change
- 05 Dec 2005 New trial record.